Cardiologist: Bruce E. Lewis, MD | Loyola Medicine

COVID-19 (Coronavirus) Update

Loyola Medicine is resuming select health care services. Learn more about resumption of services.

Bruce E. Lewis, MD

Bruce E. Lewis, MD

Medicine

Cardiology
Professor

Languages Spoken

English, Spanish
Patient Ratings
4.9 / 5 (243 Ratings)

Clinical Expertise

  • Vascular Intervention

About Dr. Lewis

Interests
Basketball, Tennis, Gardening

Medical Education

Medical School
Rush Medical College of Rush University
Residency
Rush-Presbyterian-St. Luke's Medical Center - Internal Medicine: General
Fellowship
  • Loyola University Medical Center - Cardiology

Board Certification

American Board of Internal Medicine Subspecialty Interventional Cardiology
American Board of Internal Medicine, Interventional Cardiology
Cardiovascular Disease, American Board of Internal Medicine Subspecialty, Cardiology

Research

  • Endovascular Repair of Bilateral Internal Mammary Artery Aneurysms in a Patient with Marfan Syndrome-A Case Report Alhawasli, H.; Darki, A.; Lewis, B. E., The International journal of angiology : official publication of the International College of Angiology, Inc
  • ATA Practice Guidelines for Live On Demand Primary and Urgent Care, Gough, F.; Budhrani, S.; Cohn, E.; Dappen, A.; Leenknecht, C.; Lewis, B.; Mulligan, D. A.; Randall, D.; Rheuban, K.; Roberts, L.; Shanahan, T. J.; Webster, K.; Krupinski, E. A.; Bashshur, R.; Bernard, J., Telemedicine journal and e-health : the official journal of the American Telemedicine Association
  • Comparison of primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction during and prior to availability of an in-house STEMI system: early experience and intermediate outcomes of the HARRT program for achieving routine D2B times <60 minutes Nguyen, B.; Fennessy, M.; Leya, F.; Nowak, W.; Ryan, M.; Freeberg, S.; Gill, J.; Dieter, R. S.; Steen, L.; Lewis, B.; Cichon, M.; Probst, B.; Jarotkiewicz, M.; Wilber, D.; Lopez, J. J., Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
View All ResearchShow Less
  • The increasing incidence of thromboembolic events among hospitalized patients with inflammatory bowel disease Kuy, S.; Dua, A.; Chappidi, R.; Seabrook, G.; Brown, K. R.; Lewis, B.; Rossi, P. J.; Lee, C. J., Vascular
  • An open label non-randomized, prospective clinical trial evaluating the immunogenicity of branded enoxaparin versus biosimilars in healthy volunteers., Gomes, M.; Ramacciotti, E.; Hoppensteadt, D.; Walenga, J. M.; Lewis, B.; Thethi, I.; Fareed, J., Clinical & Applied Thrombosis/Hemostasis
  • Usefulness of wide pulse pressure as a predictor of poor outcome after renal artery angioplasty and stenting. Dieter, R. S.; Darki, A.; Nanjundappa, A.; Chhokar, V. S.; Khadim, G.; Morshedi-Meibodi, A.; Freihage, J. H.; Steen, L.; Lewis, B.; Leya, F., American Journal of Cardiology
  • Argatroban in percutaneous coronary indications Iqbal, O.; Adiguzel, C.; Lewis, B. E.; Cunanan, J.; Fareed, J., Seminars in Thrombosis and Hemostasis
  • Femoral angiogram prior to arteriotomy closure device does not reduce vascular complications in patients undergoing cardiac catheterization. Ramana, R. K.; Singh, A.; Dieter, R. S.; Moran, J. F.; Steen, L.; Lewis, B. E.; Leya, F., Journal of interventional cardiology
  • Long-term clinical outcomes of real-world experience using sirolimus-eluting stents in saphenous vein graft disease Ramana, R. K.; Ronan, A.; Cohoon, K.; Homan, D.; Sutherland, J.; Steen, L.; Liu, J.; Loeb, H.; Lewis, B. E., Catheterization & Cardiovascular Interventions
  • Percutaneous coronary intervention in patients with acute coronary syndrome: focus on bivalirudin Ramana, R. K.; Lewis, B. E., Vascular Health & Risk Management
  • Predictors of clinical outcome in patients with heparin-induced thrombocytopenia treated with direct thrombin inhibition. Kelton, J. G.; Hursting, M. J.; Heddle, N.; Lewis, B. E., Blood Coagulation & Fibrinolysis
  • Direct thrombin inhibition during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia Lewis, B. E.; Hursting, M. J., Expert Review of Cardiovascular Therapy
  • Invasive assessment of mitral regurgitation: comparison of hemodynamic parameters. Freihage, J. H.; Joyal, D.; Arab, D.; Dieter, R. S.; Loeb, H. S.; Steen, L.; Lewis, B.; Liu, J. C.; Leya, F., Catheterization & Cardiovascular Interventions
  • Presence of asymmetric dimethylarginine gradients across high-grade lesions in patients with coronary artery disease. Joyal, D.; Leya, F.; Al Chekakie, M. O.; Arab, D.; Dieter, R. S.; Morshedi-Meibodi, A.; Lewis, B.; Steen, L.; Fareed, J.; Hoppenstead, D.; Akar, J. G., Coronary artery disease
  • The influence of low (81 mg) versus high (325 mg) doses of ASA on the incidence of sirolimus-eluting stent thrombosis. Joyal, D.; Freihage, J. H.; Cohoon, K.; Tempelhof, M.; Leya, F.; Dieter, R. S.; Steen, L.; Lewis, B.; Arab, D., Journal of Invasive Cardiology
  • Troponin I levels in patients with preeclampsia. Joyal, D.; Leya, F.; Koh, M.; Besinger, R.; Ramana, R.; Kahn, S.; Jeske, W.; Lewis, B.; Steen, L.; Mestril, R.; Arab, D., American Journal of Medicine
  • Utility of BNP in differentiating constrictive pericarditis from restrictive cardiomyopathy in patients with renal insufficiency. Reddy, P. R.; Dieter, R. S.; Das, P.; Steen, L. H.; Lewis, B. E.; Leya, F. S., Journal of cardiac failure
  • Clinical experience with rotational atherectomy in patients with severe left ventricular dysfunction Ramana, R. K.; Joyal, D.; Arab, D.; Dieter, R. S.; Steen, L.; Lewis, B.; Leya, F., Journal of Invasive Cardiology
  • Effects of argatroban therapy demographic variables, and platelet count on thrombotic risks in heparin-induced thrombocytopenia, Lewis, B. E.; Wallis, D. E.; Hursting, M. J.; Levine, R. L.; Leya, F., Chest
  • Antiplatelet therapy in anticoagulated patients requiring coronary intervention Arab, D.; Lewis, B.; Cho, L.; Steen, L.; Joyal, D.; Leya, F., Journal of Invasive Cardiology
  • Coronary artery perforation during percutaneous coronary intervention: incidence and outcomes in the new interventional era Ramana, R. K.; Arab, D.; Joyal, D.; Steen, L.; Cho, L.; Lewis, B.; Liu, J.; Loeb, H.; Leya, F., Journal of Invasive Cardiology
  • The efficacy of brain natriuretic peptide levels in differentiating constrictive pericarditis from restrictive cardiomyopathy. Leya, F. S.; Arab, D.; Joyal, D.; Shioura, K. M.; Lewis, B. E.; Steen, L. H.; Cho, L., Journal of the American College of Cardiology
  • Thiazolidinediones do not reduce target vessel revascularization in diabetic patients undergoing percutaneous coronary intervention. Cho, L.; Lewis, B. E.; Steen, L. H.; Leya, F. S., Cardiology
  • Global anticoagulant effects of a synthetic anti-factor Xa inhibitor (DX-9065a): implications for interventional use. Tobu, M.; Iqbal, O.; Ma, Q.; Schultz, C.; Jeske, W.; Hoppensteadt, D.; Lewis, B.; Fareed, D.; Fareed, J., Clinical & Applied Thrombosis/Hemostasis
  • New catheter design for cannulation of the anomalous right coronary artery arising from the left sinus of valsalva. Qayyum, U.; Leya, F.; Steen, L.; Sochanski, M.; Grassman, E.; Cho, L.; Lewis, B., Catheterization & Cardiovascular Interventions
  • Use of lepirudin during percutaneous vascular interventions in patients with heparin-induced thrombocytopenia Cochran, K.; DeMartini, T. J.; Lewis, B. E.; O'Brien, J.; Steen, L. H.; Grassman, E. D.; Leya, F., Journal of Invasive Cardiology
  • Patency of coronary artery bypass grafts in patients with heparin-induced thrombocytopenia Liu, J. C.; Lewis, B. E.; Steen, L. H.; Grassman, E. D.; Bakhos, M.; Blakeman, B.; Wrona, L.; Leya, F., The American Journal of Cardiology
  • Bleeding complications with glycoprotein IIb/IIIa inhibitors Iqbal, O.; Walenga, J. M.; Lewis, B. E.; Bakhos, M., Drugs of today (Barcelona, Spain : 1998)